Clinical trial
A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
NCT03467477 is registered in ClinicalTrials.gov with Avid Radiopharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2
- Lead sponsor
- Avid Radiopharmaceuticals
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 8, 2018
- Completion date
- November 15, 2018
- Enrollment
- 161 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.